DEK::AFF2 fusion-associated middle ear non-keratinizing squamous cell carcinoma: A case report
- PMID: 39720645
- PMCID: PMC11514374
- DOI: 10.5306/wjco.v15.i12.1501
DEK::AFF2 fusion-associated middle ear non-keratinizing squamous cell carcinoma: A case report
Abstract
Background: Primary squamous cell carcinoma (SCC) of the middle ear is rare, with non-keratinizing basaloid types being exceptionally uncommon. Distinguishing these cancers, often caused by viral factors (e.g., human papillomavirus or Epstein-Barr virus), or specific genetic alterations (e.g., bromodomain-containing protein 4-nuclear protein in testis fusion gene or Ewing sarcoma breakpoint region 1 gene fused with FLI chromosomal rearrangement), from other cranial conditions, is difficult. The recently identified DEK::AFF2 non-keratinizing SCC (NKSCC) is a novel subtype, fitting the World Health Organization classification of head and neck neoplasms. Less than 30 cases have been reported, highlighting the need for further studies.
Case summary: A 55-year-old female patient first exhibited signs of illness over 10 years ago with persistent discomfort in the left external auditory canal, accompanied by skin irritation and bleeding. One month prior to seeking professional help, she experienced hearing loss and a sensation of obstruction in the affected ear, intermittently accompanied by ringing sounds, but no dizziness. An unusual mass was detected in the left auditory canal, confirmed through biopsy as moderately differentiated epithelial squamous cancer cells. This led to her admission to our hospital, where the final diagnosis confirmed as "NKSCC linked to a positive DEK::AFF2 fusion". The patient underwent surgical excision, followed by three cycles of local radiation therapy. Yet, metastasis to the lumbar vertebrae occurred 19 months post-treatment, followed by neck lymph node swelling detected three months after a physical examination. The patient died nine months later despite surgical removal of the metastatic lesion.
Conclusion: DEK::AFF2 gene fusion-associated NKSCC of the middle ear carries a grim prognosis and presents an emerging challenge.
Keywords: Carcinoma; Case report; DEK::AFF2; Fusion; Pathology.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
Figures




Similar articles
-
Primary Laryngeal Squamous Cell Carcinoma with DEK::AFF2 Fusion: The First Case Report.Head Neck Pathol. 2025 Apr 29;19(1):51. doi: 10.1007/s12105-025-01793-z. Head Neck Pathol. 2025. PMID: 40299135 Free PMC article.
-
Middle Ear and Temporal Bone Nonkeratinizing Squamous Cell Carcinomas With DEK-AFF2 Fusion: An Emerging Entity.Am J Surg Pathol. 2020 Sep;44(9):1244-1250. doi: 10.1097/PAS.0000000000001498. Am J Surg Pathol. 2020. PMID: 32366754
-
DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.Mod Pathol. 2021 Oct;34(10):1820-1830. doi: 10.1038/s41379-021-00846-2. Epub 2021 Jun 9. Mod Pathol. 2021. PMID: 34108636
-
DEK::AFF2 Fusion Carcinomas of Head and Neck.Adv Anat Pathol. 2023 Mar 1;30(2):86-94. doi: 10.1097/PAP.0000000000000376. Epub 2022 Oct 12. Adv Anat Pathol. 2023. PMID: 36221219 Review.
-
DEK::AFF2 Carcinoma of the Sinonasal Tract and Skull Base: A Comprehensive Review.Surg Pathol Clin. 2024 Dec;17(4):587-597. doi: 10.1016/j.path.2024.07.008. Epub 2024 Aug 17. Surg Pathol Clin. 2024. PMID: 39489551 Review.
Cited by
-
Primary Laryngeal Squamous Cell Carcinoma with DEK::AFF2 Fusion: The First Case Report.Head Neck Pathol. 2025 Apr 29;19(1):51. doi: 10.1007/s12105-025-01793-z. Head Neck Pathol. 2025. PMID: 40299135 Free PMC article.
References
-
- Yang W, Lee KW, Srivastava RM, Kuo F, Krishna C, Chowell D, Makarov V, Hoen D, Dalin MG, Wexler L, Ghossein R, Katabi N, Nadeem Z, Cohen MA, Tian SK, Robine N, Arora K, Geiger H, Agius P, Bouvier N, Huberman K, Vanness K, Havel JJ, Sims JS, Samstein RM, Mandal R, Tepe J, Ganly I, Ho AL, Riaz N, Wong RJ, Shukla N, Chan TA, Morris LGT. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25:767–775. - PMC - PubMed
-
- Ruangritchankul K, Sandison A. DEK::AFF2 Fusion Carcinomas of Head and Neck. Adv Anat Pathol. 2023;30:86–94. - PubMed
-
- Skálová A, Agaimy A, Bradova M, Poorten VV, Hanna E, Guntinas-Lichius O, Franchi A, Hellquist H, Simpson RHW, Lopéz F, Nuyts S, Chiesa-Estomba C, Ng SP, Homma A, Teng Y, Leivo I, Ferlito A. Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities. Virchows Arch. 2024;484:885–900. - PMC - PubMed
-
- Agarwal A, Bhatt AA, Bathla G, Kanekar S, Soni N, Murray J, Vijay K, Vibhute P, Rhyner PH. Update from the 5th Edition of the WHO Classification of Nasal, Paranasal, and Skull Base Tumors: Imaging Overview with Histopathologic and Genetic Correlation. AJNR Am J Neuroradiol. 2023;44:1116–1125. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous